Association of left ventricular ejection fraction improvement with prognosis in patients with cardiac sarcoidosis: insights from the ILLUMINATE-CS study
Event:
ESC Congress 2024
Topic:
Ventricular Remodelling
Session:
Cardiac amyloidosis, sarcoidosis, and inflammation
Increasing the class of foundational medication for heart failure is associated with improved prognosis in hospitalized patients with heart failure with reduced or mildly reduced ejection fraction